Prescription drug · ANDA
Amlodipine Besylate NDC 51407-951
Amlodipine besylate 10 mg/1 · Tablet · Oral · GSMS, Incorporated
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 51407-951-10 | 51407095110 | 1000 TABLET in 1 BOTTLE (51407-951-10)Marketed from Jan 22, 2025 | |
| 51407-951-90 | 51407095190 | 90 TABLET in 1 BOTTLE (51407-951-90)Marketed from Jan 22, 2025 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Amlodipine Besylate
- Generic name (nonproprietary)
- amlodipine besylate
- Active ingredients
- Amlodipine besylate — 10 mg/1
- Dosage form
- Tablet
- Route
- Oral
- Labeler
- GSMS, Incorporated
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 076719
- Marketing start
- Listing expires
- Other FDA classes
- Calcium Channel Antagonists (Mechanism)Cytochrome P450 3A Inhibitors (Mechanism)Dihydropyridines (Chemical structure)
- Identifiers
- Product ID 51407-951_a6c15fed-d823-4cd4-83fb-2773c4c3f9ceSPL ID a6c15fed-d823-4cd4-83fb-2773c4c3f9ceSPL set ID 9c0f83f4-06ad-4bb1-a8e3-dcac43b840cfRxCUI 197361, 308135UNII 864V2Q084HUPC 0351407950901, 0351407950109, 0351407951908, 0351407951106
- Pharmacologic class
- Calcium Channel Blocker; Dihydropyridine Calcium Channel Blocker
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N451407095110followed by a unit qualifier and the quantityPackage 51407-0951-10. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
Amlodipine besylate tablets is a calcium channel blocker and may be used alone or in combination with other antihypertensive and antianginal agents for the treatment of: Hypertension (1.1) Amlodipine besylate tablets are indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. Coronary Artery Disease (1.2) Chronic Stable Angina Vasospastic Angina (Prinzmetal’s or Variant Angina) Angiographically Documented Coronary Artery Disease in patients without heart failure or an ejection fraction < 40% 1.1 Hypertension Amlodipine besylate tablets are indicate…
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 076719
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Amlodipine Besylate | Amlodipine besylate 10 mg/1 | TabletOral | Aphena Pharma Solutions - Tennessee, LLC | 71610-928 |
| Amlodipine Besylate | Amlodipine besylate 5 mg/1 | TabletOral | Aphena Pharma Solutions - Tennessee, LLC | 71610-956 |
| Amlodipine Besylate | Amlodipine besylate 10 mg/1 | TabletOral | Aphena Pharma Solutions - Tennessee, LLC | 71610-988 |
| Amlodipine Besylate | Amlodipine besylate 5 mg/1 | TabletOral | GSMS, Incorporated | 51407-950 |
| Amlodipine Besylate | Amlodipine besylate 2.5 mg/1 | TabletOral | PD-Rx Pharmaceuticals, Inc. | 72789-514 |
| Amlodipine Besylate | Amlodipine besylate 5 mg/1 | TabletOral | PD-Rx Pharmaceuticals, Inc. | 72789-515 |
| Amlodipine Besylate | Amlodipine besylate 10 mg/1 | TabletOral | PD-Rx Pharmaceuticals, Inc. | 72789-516 |